Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Maida

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 31, 2024
Clinical implications for the association of psoriasis and multiple sclerosis: an observational studyGiuseppina Miele, Maddalena Sparaco, Elisabetta Maida, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2023
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosisGianmarco Abbadessa, Giuseppina Miele, Elisabetta Maida, et al.
Journal of Clinical Medicine|February 10, 2024
Neuromuscular Electrical Stimulation Does Not Influence Spinal Excitability in Multiple Sclerosis PatientsMartina Scalia, Riccardo Borzuola, Martina Parrella, et al.
Journal of Clinical Medicine|September 14, 2024
Dermatological Neoplastic Diseases Complicating Treatment with Monoclonal Antibodies for Multiple SclerosisFloriana Bile, Maddalena Sparaco, Eleonora Ruocco, et al.
Genes|June 26, 2025
Clinical Efficacy of Selumetinib in Alleviating Neuropathic Pain Associated with Plexiform Neurofibroma: A Case SeriesGiuseppina Miele, Irene Russo, Lorenzo Filipponi, et al.
Multiple Sclerosis and Related Disorders|March 19, 2022
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cellsGianmarco Abbadessa, Elisabetta Maida, Giuseppina Miele, et al.
Non-Coding RNA Research|June 13, 2025
Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosisBruna De Felice, Elisabetta Signoriello, Concetta Montanino, et al.
Molecular Neurobiology|April 30, 2026
MicroRNA-mRNA Regulatory Network Associated with Cognitive Impairment in Multiple SclerosisBruna De Felice, Federica Farinella, Giuseppe Romano, et al.
Journal of Clinical Medicine|June 26, 2025
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic ComplicationsElisabetta Maida, Paola Caruso, Simona Bonavita, et al.
Radiology Case Reports|October 16, 2023
Apparently isolated CNS involvement in Erdheim-Chester disease: Case reportGiuseppe Romano, Mario Cirillo, Simona Bonavita, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 31, 2024
Clinical implications for the association of psoriasis and multiple sclerosis: an observational studyGiuseppina Miele, Maddalena Sparaco, Elisabetta Maida, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2023
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosisGianmarco Abbadessa, Giuseppina Miele, Elisabetta Maida, et al.
Journal of Clinical Medicine|February 10, 2024
Neuromuscular Electrical Stimulation Does Not Influence Spinal Excitability in Multiple Sclerosis PatientsMartina Scalia, Riccardo Borzuola, Martina Parrella, et al.
Journal of Clinical Medicine|September 14, 2024
Dermatological Neoplastic Diseases Complicating Treatment with Monoclonal Antibodies for Multiple SclerosisFloriana Bile, Maddalena Sparaco, Eleonora Ruocco, et al.
Genes|June 26, 2025
Clinical Efficacy of Selumetinib in Alleviating Neuropathic Pain Associated with Plexiform Neurofibroma: A Case SeriesGiuseppina Miele, Irene Russo, Lorenzo Filipponi, et al.
Multiple Sclerosis and Related Disorders|March 19, 2022
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cellsGianmarco Abbadessa, Elisabetta Maida, Giuseppina Miele, et al.
Non-Coding RNA Research|June 13, 2025
Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosisBruna De Felice, Elisabetta Signoriello, Concetta Montanino, et al.
Molecular Neurobiology|April 30, 2026
MicroRNA-mRNA Regulatory Network Associated with Cognitive Impairment in Multiple SclerosisBruna De Felice, Federica Farinella, Giuseppe Romano, et al.
Journal of Clinical Medicine|June 26, 2025
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic ComplicationsElisabetta Maida, Paola Caruso, Simona Bonavita, et al.
Radiology Case Reports|October 16, 2023
Apparently isolated CNS involvement in Erdheim-Chester disease: Case reportGiuseppe Romano, Mario Cirillo, Simona Bonavita, et al.
Pageof 3